Europe Pharmaceutical Fill and Finish Outsourcing Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Pharmaceutical Fill and Finish Outsourcing Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Pharmaceutical Fill and Finish Outsourcing Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Pharmaceutical Fill and Finish Outsourcing Market Regional Analysis

6.2 Europe Pharmaceutical Fill and Finish Outsourcing Market Revenue 2019-2028 (US$ Million)

6.3 Europe Pharmaceutical Fill and Finish Outsourcing Market Forecast Analysis

7. Europe Pharmaceutical Fill and Finish Outsourcing Market Analysis – by State of Finished Product

7.1 Solids

7.1.1 Overview
7.1.2 Solids: Europe Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Semi-solids

7.2.1 Overview
7.2.2 Semi-solids: Europe Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Liquids

7.3.1 Overview
7.3.2 Liquids: Europe Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Europe Pharmaceutical Fill and Finish Outsourcing Market Analysis – by Content

8.1 Organic Substances Isolated from Animal Origin

8.1.1 Overview
8.1.2 Organic Substances Isolated from Animal Origin: Europe Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Organic Substances Isolated from Microorganisms

8.2.1 Overview
8.2.2 Organic Substances Isolated from Microorganisms: Europe Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Inorganic Substances

8.3.1 Overview
8.3.2 Inorganic Substances : Europe Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Europe Pharmaceutical Fill and Finish Outsourcing Market – Europe Analysis

9.1 Overview

9.2 Europe

9.2.1 Europe Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by Key Country, 2022 and 2028 (%)
9.2.1.1 Europe Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast Analysis – by Country
9.2.1.1 UK: Europe Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.1.1 UK: Europe Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by State of Finished Product
9.2.1.1.2 UK: Europe Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by Content

9.2.1.2 Germany: Europe Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.2.1 Germany: Europe Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by State of Finished Product
9.2.1.2.2 Germany: Europe Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by Content

9.2.1.3 France: Europe Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.3.1 France: Europe Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by State of Finished Product
9.2.1.3.2 France: Europe Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by Content

9.2.1.4 Russia: Europe Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.4.1 Russia: Europe Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by State of Finished Product
9.2.1.4.2 Russia: Europe Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by Content

9.2.1.5 Italy: Europe Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.5.1 Italy: Europe Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by State of Finished Product
9.2.1.5.2 Italy: Europe Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by Content

9.2.1.6 Rest of Europe: Europe Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.6.1 Rest of Europe: Europe Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by State of Finished Product
9.2.1.6.2 Rest of Europe: Europe Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by Content

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 Abbott

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 TEVA PHARMACEUTICAL INDUSTRIES LTD

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Dr. Reddy's Laboratories

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Sun Pharmaceutical Industries Ltd

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Piramal Enterprises Ltd.

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 WOCKHARDT

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 Cytovance Biologics

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 Thermo Fisher Scientific Inc. (Patheon N.V)

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 Boehringer Ingelheim International GmbH

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

Europe Pharmaceutical Fill and Finish Outsourcing Market

Analysis By State of Finished Product (Solids, Semi-solids, and Liquids), Content (Organic Substances Isolated from Animal Origin, Organic Substances Isolated from Microorganisms, and Inorganic Substances)